ADM and CJ CheilJedang Form Amino Acid Joint Venture to Bolster U.S. Supply
ADM sits 43% above its 52-week low of $55.58.
Summary
ADM and South Korea's CJ CheilJedang are forming a joint venture to produce feed-grade amino acids, combining CJ's fermentation technology and facilities in Iowa and Brazil with ADM's Decatur, Illinois plant. CJ will be the majority owner, and the JV gets exclusive rights to manufacture and sell these amino acids in the Americas. The deal aims to secure domestic lysine supply after recent U.S. trade rulings against Chinese imports. This is a strategic expansion for ADM's nutrition business, though financial terms were not disclosed. Regulatory approvals and closing conditions still need to be met.
At the time of this announcement, ADM was trading at $79.37 on NYSE in the Trade & Services sector, with a market capitalization of approximately $38.3B. The 52-week trading range was $55.58 to $88.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.